Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 38 Neoplasm Metastasis 14 Liver Neoplasms 11 Colorectal Neoplasms 11 Cholangiocarcinoma 9 Pancreatic Neoplasms 8 Lung Neoplasms 8 Colonic Neoplasms 7 Breast Neoplasms 7 Thyroid Nodule 6 Recurrence 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Thyroid Neoplasms 5 Rectal Neoplasms 4 Neoplasms 4 Esophageal Neoplasms 4 Prostatic Neoplasms 3 Pain 3 Kidney Neoplasms 3 Barrett Esophagus 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Leiomyoma 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2 Bile Duct Neoplasms 2 Adrenocortical Adenoma 2

Interventions

Liver Transplantation 4 Gemcitabine 4 Cisplatin 4 Capecitabine 4 Radiosurgery 3 toripalimab 2 Specimen Handling 2 Self Expandable Metallic Stents 2 Platinum 2 Oxaliplatin 2 Magnetic Resonance Spectroscopy 2 Fluorouracil 2 1,2-diaminocyclohexaneplatinum II citrate 2 trisacryl gelatin microspheres 1 tremelimumab 1 tislelizumab 1 temoporfin 1 sacituzumab govitecan 1 ricolinostat 1 pembrolizumab 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 fludarabine 1 durvalumab 1 Saline Solution 1 Radiofrequency Ablation 1 Photosensitizing Agents 1 Photochemotherapy 1 Pancreatic Hormones 1 Optical Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Klatskin Tumor × Radiofrequency Ablation × Clear all

NCT05551299 2025-03-27

CARP

University of Leipzig

Phase 4 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡